Pyxis Oncology Appoints Thomas Civik CEO and Chairman
Pyxis Oncology appointed Thomas Civik as its new CEO and Chairman following his tenure as Interim CEO. The leadership transition sets the stage for advancing key clinical milestones.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day